Consistent with previous lung and cervical cancer studies, we found that TIM was overexpressed in lung cancer and TIM inhibition has a modest antitumor effect in lung cancer, but more robust evidence showed that TIM was partially involved in TRF-mediated tumor suppression. The gene discussed is TIMELESS; the disease is cervical carcinoma.